INS and hyperinsulinemic hypoglycemia: To determine the effectiveness of loss of Prkar1a on hyperinsulinemic hypoglycemia, mice were implanted with an osmotic pump delivering either vehicle, 0.2U or 0.3U/day of insulin 16 days after they were injected with siPrkar1a or control.